The contractile and biochemical effects of the divalent cation ionophore A23187 were studied in isolated perfused guinea pig and rat ventricles. A23187 increased both cyclic adenosine 3':5'monophosphate (cyclic AMP) and cyclic guanosine 3':5'-monophosphate (cyclic GMP) concentrations in guinea pig ventricles. Associated with these changes in nucleotide content were positive inotropic effects and activation of giycogen phosphorylase. Pretreatment of «nirrmln with reserpine to deplete endogenous catecholamine stores or pretreatment of hearts with propranolol failed to alter these ionophore-induced change*. In contrast, blockade of histamine (Hi) receptors with metiamide completely abolished the positive inotropic effects and activation of giycogen phosphorylase induced by A23187. In these metiamide-treated hearts, the ionophore-induced increase in cyclic AMP concentration was significantly attenuated, whereas the increase in cyclic GMP content persisted. A23187 produced a negative inotropic effect in hearts taken from rats treated with reserpine. In these rat hearts, cyclic AMP levels and giycogen phosphorylase activity were unchanged, whereas cyclic GMP concentrations were markedly increased. These results indicate that A23187 produces both indirect and direct effects on guinea pig ventricles. The indirect effects are mediated primarily by histamine, presumably released from tissue mast cells by the ionophore. Histamine in turn increases cyclic AMP levels, which leads to activation of phosphorylase and positive inotropic effects. The direct biochemical effect of A23187 is an increase in cyclic GMP concentrations. Ore Rea
IONOPHORES such as X537A, monensin, and A23187 have been used in attempts to alter the intracellular concentration of free calcium or sodium in the myocardium and thereby further define the roles of these cations in regulating cardiac function (Holland et al., 1975; Pressman, 1973; Pressman and deGuzman, 1975; Schaffer et al., 1974; Schwartz et al., 1974; Sutko et al., 1977) . Of these, A23187 has been shown to have some specificity for calcium, although the ionophore also transports magnesium and hydrogen ions across biological membranes (Reed and Lardy, 1972) . Although A23187 has been used by several investigators in studies of calcium accumulation by isolated sarcoplasmic reticulum vesicles (Entman et al., 1972; Scarpa et al., 1972; Jones et al., 1977) , this ionophore has not been studied extensively in intact cardiac tissue, perhaps because its functional effects appear minimal in whole tissues. In the studies of Schaffer et al. (1974) and Schwartz et al. (1974) , A23187 failed to produce effects on contraction parameters of ventricular or atrial myocardium. In only one published study has A23187 been demonstrated to produce concentration-dependent increases in contractility of guinea pig left atrial preparations (Holland et al., 1975) .
In spite of the apparent lack of functional effects of A23187 in intact myocardium, it would appear that .the ionophore might produce significant changes in the activities of enzymes that are known to be modulated by the free intracellular calcium concentration. Phosphorylase b kinase, which converts giycogen phosphorylase from the inactive (b) to the active (a) form, requires calcium for catalytic activity (Friesen et al., 1969; Namm et al., 1968) . Similarly, guanylate cyclase, which catalyzes the conversion of guanosine triphosphate to cyclic guanosine 3':5'-monophosphate (cyclic GMP), can be directly stimulated by physiological, concentrations of calcium (Wallach and Pastan, 1976) , and appears to require calcium for increased catalytic activity in response to hormonal stimulation (Schultz et al., 1973) . On the other hand,adenylate cyclase, which catalyzes the formation of cyclic adenosine 3':5'monophosphate (cyclic AMP) from adenosine triphosphate (ATP), is inhibited by increased calcium concentrations (Campbell and Siddle, 1976; Stole, 1977) . It seems likely, therefore, that A23187,. by altering the intracellular calcium concentration in the myocardium, might alter cyclic nucleotide concentrations and giycogen phosphorylase activity in intact hearts. The purpose of the present study was to examine the effects of A23187 on the contractile properties, cyclic AMP and cyclic GMP concentra-tions, and glycogen phosphorylase activity of intact ventricular myocardium.
Methods

Heart Perfusion
Hearts were obtained from male or female guinea pigs or rats weighing 300-350 g. Some animals were pretreated with reserpine, 3 mg/kg (intraperitoneally), 18 hours prior to the experiments. Thirty minutes after the intraperitoneal administration of heparin sulfate (500 U), each animal was stunned by a blow to the head, and its heart was rapidly removed and placed in ice-cold oxygenated (95% O 2 -5% CO 2 ) Krebs-Henseleit buffer to remove the blood. The composition of <\e buffer was (in mM): NaHC0 3 , 27.2; NaCl, 118.0; KC1, 4.8; KH 2 PO 4 , 1.0; MgSO.,, 1.2; CaCl 2 , 2.5 (guinea pig hearts) or 1.25 (rat hearts); and glucose, 11.1. The heart was perfused by the Langendorff technique with oxygenated Krebs-Henseleit buffer at a constant flow rate of 4.0 (guinea pig hearts) or 8.0 (rat hearts) ml/min. Immediately after perfusion was begun, the atria were removed, and the apex of the heart was connected to a strain gauge transducer (Grass Instruments, FTO3-C) by a silk suture. Five grams of diastolic tension were applied to each heart at the beginning of the experiment. The hearts were continuously paced at 3 (guinea pig hearts) or 3.5 Hz (rat hearts) by 10-msec electrical impulses at voltages 10-25% above threshold. The entire perfusion apparatus was enclosed in an organ perfusion box that maintained temperature at 30°C (guinea pig hearts) or 37°C (rat hearts) and humidity at 100%. Perfusion pressure, developed tension, and the first derivative of developed tension (dT/dt) were continuously recorded. Changes in developed tension and dT/dt were always qualitatively similar. Therefore, all analyses of changes in contractility were made on the basis of changes in dT/dt. The hearts were allowed to stabilize for 10-15 minutes prior to any drug treatments. All drugs were administered by continuous infusion (0.4 ml/ min) via a sidearm, which entered the main perfusion stream 3 cm from the coronary arteries. A23187 was dissolved in absolute ethanol. This stock solution was diluted with distilled water to give a working solution which, after being mixed in the main perfusion stream, yielded the final desired concentration of A23187. The ionophore was always delivered in the presence of 0.5% ethanol. All hearts received this concentration of ethanol, which resulted in a slight (less than 10%) reduction in contractility, for 10-15 minutes prior to exposure to the ionophore. Where indicated, the various antagonists (propranolol, atropine, or metiamide) were included in the 10-to 15-minute preperfusion with ethanol and continued during administration of A23187. At the specified times, hearts were frozen with metal tongs precooled in liquid nitrogen, pul-verized with a precooled (-196°C) mortar and pestle, and stored under liquid nitrogen until assay.
Biochemical Assays
Cyclic AMP and cyclic GMP concentrations were measured by radioimmunoassay as previously described (Watanabe and Besch, 1975) , except that both cyclic nucleotides were succinylated to increase the sensitivity of the assay. Glycogen phosphorylase a activity was determined by a modification of the method of Gilboe et al. (1972) as previously described (Farmer et al., 1977) . Briefly, the incorporation of the glycosyl moiety of glucose-1-phosphate into glycogen was measured in the presence and absence of 3 mM 5'-AMP. ATP and creatine phosphate (CP) were measured by spectrophotometric methods (Lamprecht and Stein, 1963) .
Statistical Analysis
All results are expressed as the mean ± standard error of the mean. The differences between means were compared by use of unpaired £-tests (Dixon and Massey, 1969) and were considered significant when P < 0.05.
Materials
Antiserum to cyclic AMP was obtained from Collaborative Research or Research Products, Inc., and antiserum to cyclic GMP was obtained from Collaborative Research or Schwarz/Mann. [ 3 H]cyclic AMP (specific activity, 36.6 Ci/mmol) and glucose-1-phosphate [ U C-(U)] (specific activity, 222.7 Ci/mmol) were obtained from New England Nuclear. [ 3 H]-cyclic GMP (specific activity, 19 Ci/ mmol) was obtained from Amersham/Searle. The 12s I-labeled tyrosine methyl esters of cyclic AMP and cyclic GMP were obtained from Collaborative Research. A23187 was a gift of Eli Lilly and Company. Reserpine (Serpasil), /-propranolol hydrochloride, and metiamide hydrochloride were the gifts of Ciba Pharmaceutical Company, Ayerst Laboratories, and Smith, Kline & French Laboratories, respectively. Atropine sulfate, /-isoproterenol bitartrate, histamine hydrochloride, and all enzymes and cofactors required for the ATP and CP assays were obtained from Sigma Chemical.
Results
Because of the likelihood that A23187 would produce effects not only on myocardial tissues but also on noncardiac tissues (e.g., sympathetic nerves or mast cells) in the heart (Cochrane and Douglas, 1974; Thoa et al., 1974) , it was necessary to perform several different types of experiments to define fully the cardiac effects of the ionophore. In the first series of experiments A23187 was given alone. Subsequent experiments were designed to separate the indirect from the direct effects of the ionophore. Thus, A23187 was given to hearts from animals pretreated with reserpine or during simultaneous VOL.44, No. 4, APRIL 1979 administration of propranolol to eliminate indirect effects mediated by norepinephrine released from sympathetic nerve endings. In addition, the ionophore was given to hearts in which histamine (H 2 ) receptors were blocked, to obviate the indirect effects of histamine released from tissue mast cells (Verma and McNeill, 1976) .
Effects of A23187 When Given Alone to Isolated Guinea Pig Hearts
Contractility and Phosphorylase Activity A23187 was given alone in two concentrations, 1 and 3 /XM. The ionophore produced time-and concentration-dependent changes in both contractility and phosphorylase a activity. With 1 /UM A23187, the contractile function of the ventricles did not change until after 120 seconds of continuous perfusion, at which time contractility began to increase ( Fig. 1 ). Values of dT/dt continued to increase to 180% of control values and remained stable for up to 4.5 minutes of continuous perfusion with the drug. Activation of phosphorylase with 1 jtM A23187 paralleled the changes in dT/dt ( Fig. 1) . Phosphorylase a activity increased from a basal value of 11.2 ± 0.9% only after 180 seconds of continuous perfusion with the ionophore, and the level of phos- phorylase reached a peak value of 49.1 ± 4.9% after 270 seconds of drug perfusion (Fig. 1) .
The pattern of response to 3 /IM A23187 was somewhat different. The onset of the positive inotropic effect occurred earlier, before 120 seconds of continuous perfusion, and dT/dt peaked after 180 seconds of drug perfusion and then began to fall, reaching control levels after 270 seconds of perfusion (Fig. 1) . The decline in contractility was associated with a rise in diastolic tension indicating development of contracture. Similarly, phosphorylase a activity was increased earlier, reaching a peak value of 55.0 ± 5.0% after 180 seconds of perfusion ( Fig. 1 ).
Cyclic Nucleotide Concentrations
With 1 jiM A23187, cyclic AMP content increased quite rapidly and was significantly elevated after only 30 seconds of drug perfusion (Fig. 1 ). The concentration of cyclic AMP continued to increase during the subsequent 2 minutes of drug perfusion, and then remained elevated for up to 4.5 minutes of perfusion. Cyclic GMP levels also rose rapidly with A23187 treatment (Fig. 1) . In contrast to the changes in cyclic AMP levels, the concentration of cyclic GMP reached maximal values after 30 seconds of A23187 perfusion and remained stable at this level for up to 4.5 minutes of perfusion ( Fig. 1) .
Cyclic AMP levels after 180 seconds of perfusion with 3 IJM A23187 were similar to those seen after the same duration of perfusion with 1 fitA. However, after 270 seconds of perfusion, when dT/dt had fallen to control levels, cyclic AMP concentrations had fallen to 0.88 ± 0.15 pmol/mg wet weight. A similar pattern of change in cyclic GMP levels was seen with 3 / XM A23187. Cyclic GMP content was 60.5 ± 6.6 fmol/mg wet weight after 180 seconds of drug perfusion, but fell to 32.0 ± 7.6 fmol/mg wet weight after 270 seconds of continuous perfusion with the ionophore.
Lack of Modification of the Contractile or Metabolic Effects of A23187 in Guinea Pig Hearts by Reserpine or Propranolol
Ionophore-induced increases in cyclic AMP, phosphorylase activity, and contractility could have been due to indirect actions of the drug mediated by release of endogenous catecholamines. Therefore, the series of experiments described in this section were conducted under two conditions designed to obviate the effects of released catecholamines: catecholamine depletion produced by reserpine pretreatment, and /?-adrenergic receptor blockade. Hearts obtained from animals treated with reserpine (3 mg/kg, intraperitoneally, 18 hours prior to experiment) failed to show a positive inotropic response to 4.0 /IM tyramine. Likewise, the simultaneous administration of 3.0 /iM /-propranolol abolished the positive inotropic effect of 0.1 J^M lisoproterenol.
Contractility and Phosphorylase Activity
A23187 produced a positive inotropic effect and activated phosphorylase in hearts from reserpinepretreated animals or during simultaneous administration of propranolol ( Fig. 2A ). The response of these two parameters to A23187 seemed to differ depending on whether tissue catecholamines had been depleted by reserpine or /8-adrenergic receptors were blocked by propranolol (Fig. 2) . In propranolol-treated hearts, the threshold concentration of A23187 for increasing contractility was 0.1 JUM, and the peak response occurred at 1.0 \itA. In contrast, the threshold concentration of A23187 for increasing contractility in hearts from reserpinepretreated animals was 0.3 [IM, and the peak response occurred at 3.0 fiM. The order of sensitivity was reversed when phosphorylase activity was assessed (Fig. 2B ). The hearts from reserpine-treated animals appeared to be more sensitive to lower concentrations of A23187 than those receiving propranolol. In the former, the threshold concentration of A23187 for activating phosphorylase was 0.1 ^M, whereas in the latter the threshold concentration was 0.3 /KM. The peak response for both groups of hearts occurred at 3.0 JIM A23187. The effects of A23187 on contractility in hearts from reserpine-pretreated animals and in propranolol-pretreated hearts also were time-dependent ( Fig. 3 ). Low concentrations (0.01-0.1 /IM) produced a slowly developing negative inotropic effect, whereas higher concentrations (0.3-10 fiM) produced positive inotropic effects in which the time to onset of the response was inversely related to the drug concentration. A23187 (10 /IM) produced a rapid but brief increase in contractility which then rapidly declined with the development of contracture.
-
Cyclic Nucleotide Concentrations
A23187 increased the concentrations of both cyclic AMP and cyclic GMP in the hearts of reserpine-pretreated animals or in those hearts receiving propranolol (Fig. 4) . The threshold concentration for increasing cyclic AMP levels in the hearts from reserpine-pretreated guinea pigs was 0.1 JIM A23187, whereas all concentrations of ionophore significantly increased cyclic AMP levels in hearts treated with propranolol. Cyclic AMP levels were maximally elevated with 0.3 JIM A23187, and the levels VOL. 44, No. 4 declined with higher concentrations of the ionophore. In addition, the magnitude of cyclic AMP increase (up to 400% of control values with 0.3 ^IM A23187) was greater in the propranolol-treated hearts, in which basal levels of cyclic AMP were significantly lower than in hearts from reserpinepretreated animals (0.56 ± 0.03 vs. 0.34 ± 0.03 pmol/ mg wet weight).
All concentrations of the ionophore studied increased tissue levels of cyclic GMP. At the lowest concentration tested (0.01 /XM), cyclic GMP levels were doubled after 270 seconds of drug exposure. The concentration-response curve was biphasic, with up to 10-fold increases in cyclic GMP levels occurring at 0.3-1.0 JIM A23187. At higher concentrations of the ionophore, cyclic GMP content fell toward basal levels.
Pretreatment of the perfused hearts with atropine (1 /IM) did not attenuate the maximal increases in cyclic GMP produced by 0.3 jtM A23187 in reserpine-pretreated ventricles, nor did it alter the submaximal increases produced by 0.03 (AM A23187 in hearts that had been pretreated with propranolol (3 n*i) (Table 1 ). Figure 5 shows the time course of the changes in cyclic nucleotide levels and phosphorylase activity in response to 1.0 / XM A23187 given to hearts pretreated with 3.0 [OA propranolol. Both cyclic GMP and cyclic AMP concentrations increased rapidly, the levels of both nucleotides being significantly elevated after 30 seconds of perfusion with A23187. After 60 seconds of perfusion with the ionophore, cyclic GMP levels appeared to reach maximal values and persisted at these levels for up to 180 seconds of perfusion. Cyclic AMP levels continued to increase throughout the period studied and reached maximal levels at 180 seconds of perfusion. The positive inotropic and metabolic responses were delayed, even though cyclic nucleotide levels changed quite rapidly. Phosphorylase activity and contractility were not significantly increased until after 60 and 120 seconds, respectively, of perfusion with A23187. It is apparent from Figure 5 that propranolol did not significantly alter the contractile or biochemical responses of hearts to 1 /iM A23187.
Abolition of the Positive Inotropic and Metabolic Effects of A23187 in Guinea Pig
Hearts by Metiamide
The results described in the previous section indicated that A23187 elevated cyclic AMP levels, increased contractility, and activated phosphorylase, even after tissue catecholamine stores had been depleted or /J-adrenergic receptors had been blocked by propranolol. The possibility remained that these ionophore-induced effects were secondary to those produced by histamine released from tissue mast cells. To test this possibility, experiments were performed with metiamide, an H2 receptor antagonist that has been shown to block the inotropic effects of histamine in guinea pig hearts (Verma and McNeill, 1976) .
Contractility and Phosphorylase Activity
Metiamide alone (10 JUM) did not alter contractility of guinea pig hearts. In hearts pretreated with this H 2 receptor blocker, the positive inotropic effects of A23187 were abolished (Fig. 6A) . Instead, hearts treated in this manner exhibited a small reduction in contractility, which became apparent after 180 seconds of perfusion with the ionophore. The effects of A23187 on phosphorylase activity also were abolished by metiamide ( Fig. 6A) . Similar effects were seen when A23187 was given simultaneously with both propranolol and metiamide (Fig.  6B) . The contractile and metabolic effects of A23187 given during blockade of both /8-adrenergic and H2 receptors were identical to those seen during H2 receptor blockade alone.
Cyclic Nucleotide Concentrations
The increase in cyclic GMP levels in response to A23187 appeared to be attenuated slightly by metiamide; however, the cyclic GMP level was significantly reduced (when compared to A23187 alone) only at 120 seconds of drug exposure in the presence of metiamide.
Metiamide alone appeared to cause slight increases in tissue cyclic AMP levels. In hearts also receiving propranolol, this increase in cyclic AMP VOL. 44, No. 4, APRIL 1979 content was statistically significant ( Fig. 6B ; zero time point in hearts receiving both propranolol and metiamide). Metiamide also attenuated the magnitude of the increase in cyclic AMP levels in response to A23187 (Fig. 6, A and B) .
Because the basal level of cychc AMP was increased by metiamide treatment alone (Fig. 6B) , the amount of attenuation of cychc AMP generation in response to A23187 induced by metiamide was not readily apparent when absolute values of cychc AMP were examined. The data were therefore expressed in terms of percent control values (Fig. 7A ). When the data were expressed in this manner, it became apparent that metiamide, when given alone or with propranolol, markedly attenuated the magnitude of cyclic AMP generation in response to A23187 (Fig. 7A ). It is also apparent from this figure that propranolol produced no attenuation of cychc AMP generation at the times studied, but rather actually augmented the generation of the nucleotide in response to A23187.
Phosphorylase activity is expressed in terms of percent control values in Figure 7B . It is evident that phosphorylase activity ratios faithfully followed changes in cychc AMP values expressed as percent control (compare parts A and B of Figure  7 ).
Effect of A23187 on Isolated Hearts Taken from Reserpine-Treated Rats
The experiments with guinea pig hearts suggested that the indirect effects of A23187 were mediated primarily by histamine released from tissue mast cells and possibly to a lesser extent by released catecholamines. Since rat hearts do not possess histamine receptors, it was possible to examine the direct effects of A23187 in this species simply by depleting the tissue catecholamine stores.
Contractility and Phosphorylase Activity
In the hearts from reserpine-treated rats, 3.0 ftM A23187 produced only a negative inotropic effect which developed slowly, reaching maximum at 60 seconds when contractility was reduced 14% below control levels. Phosphorylase a activity was unchanged in these hearts (Fig. 8) .
Cyclic Nucleotide Concentrations
Cychc GMP levels increased during the first 60 seconds of A23187 perfusion and peaked at a level of 48.2 ± 10.4 fmol/mg wet weight at 60 seconds (Fig. 8) . Thereafter, cyclic GMP content fell, approaching basal levels at 120 seconds. In contrast, cychc AMP levels were unchanged by A23187 (Fig.  8 ).
ATP and CP Concentrations
ATP and CP concentrations were not changed in hearts receiving A23187 for 120 seconds (Fig. 8) .
These data indicate that the negative inotropic effects of the ionophore could not be attributed to depletion of high energy compounds in the myocardial cell.
Discussion
The results of the present study indicate that the divalent cation ionophore A23187 produces both indirect and direct effects on guinea pig ventricular myocardium. The indirect effects are produced primarily by histamine released from tissue mast cells located within the ventricular myocardium ( Figs. 6  and 7) . Several recently published studies have demonstrated that A23187 in the presence of Ca 2+ in the medium induces release of histamine from tissue mast cells (Cochrane and Douglas, 1974; Diamant and Patkar, 1975; Pearce et al., 1978) . In the present study, histamine released from tissue stores in turn stimulated histamine H 2 receptors on myocardial cells, and thereby activated myocardial adenylate cyclase and increased tissue cyclic AMP levels (Verma and McNeill, 1976; Watanabe and Besch, 1974) . The changes in cyclic AMP levels, secondary to the action of histamine, were responsible for the positive inotropic effects and activation of phosphorylase in hearts given A23187 alone (Verma and McNeill, 1976; Watanabe and Besch, 1974) . That this is the mechanism of the indirect effects of A23187 is supported by the studies with metiamide and the experiments on rat hearts. Metiamide is an H 2 receptor blocker that antagonizes the effects of histamine on guinea pig hearts (Verma and McNeill, 1974) . When A23187 was given to metiamide-treated hearts, the positive inotropic effect of the ionophore was abolished (Fig. 6) . Instead, these hearts responded to the compound with a slowly developing negative inotropic response. The in-creases in phosphorylase a activity produced by the ionophore also were abolished by H2 receptor blockade. In these same hearts, the augmentation in tissue cyclic AMP levels, which presumably mediated the effects of histamine, also were attenuated (Figs. 6 and 7) . Our conclusion that the positive inotropic and metabolic effects of A23187 were mediated indirectly primarily by ionophore-induced release of histamine was supported by the studies with rat hearts. Rat hearts do not possess histamine receptors (Dai, 1976) . Therefore, possible indirect effects of the ionophore could be eliminated by reserpine pretreatment of the rats to deplete endogenous catecholamine stores. Hearts from rats treated in such a manner did not develop increases in myocardial contractility or activation of phosphorylase in response to the ionophore. Likewise, cyclic AMP levels in those hearts were unchanged by A23187 (Fig. 8) .
Although it previously had been shown by Thoa et al. (1974) that A23187 induced release of endogenous catecholamines from sympathetic nerves innervating guinea pig vas deferens, ionophore-induced release of tissue catecholamines apparently did not occur to any significant degree in the present studies. Thus, the indirect effects of the ionophore appeared not to be mediated primarily via activation of adrenergic receptors by endogenous catecholamines. This conclusion is supported by the finding that neither propranolol nor reserpine pretreatment altered the effects of A23187 in guinea pig hearts (Figs. 2 and 4) . Further, the positive inotropic and phosphorylase-activating effects of A23187 were abolished by metiamide, whether the H2 receptor antagonist was given alone or simultaneously with propranolol ( Fig. 6) .
In hearts treated with A23187 alone or in hearts in which the effects of released catecholamines were abolished (i.e., those hearts in which histamine effects were manifest), the onset of the positive inotropic effects and the activation of phosphorylase were delayed. These responses did not become manifest until after 2 minutes of perfusion with the ionophore, even though cyclic AMP levels increased rapidly and were significantly elevated after only 30 seconds of drug perfusion (Figs. 1 and 5) . Thus there appeared to be a partial dissociation between increases in tissue cyclic AMP levels and the positive inotropic and metabolic responses of the hearts. In these two groups of hearts, cyclic AMP levels had to exceed about 1.0 pmol/mg wet weight before positive inotropic and metabolic effects were detectable. Even in the presence of both H 2 and /?adrenergic receptor blockade, A23187 still produced a small increase in cyclic AMP levels, perhaps because of incomplete blockade of H 2 receptors (Figs.  6 and 7) . It should be noted, however, that in these hearts the threshold concentration of cyclic AMP required to produce positive inotropic effects or to activate phosphorylase probably was not reached, because neither of these parameters was affected by the ionophore. Cyclic AMP levels in these hearts VOL. 44, No. 4, APRIL 1979 never exceeded 1.0 pmol/mg wet weight. This level of cyclic AMP is substantially higher than that usually seen in association with marked positive inotropic or metabolic effects of hormones such as isoproterenol or glucagon (Mayer et al., 1970; Watanabe and Besch, 1974) . Thus, in hearts receiving A23187 the responsiveness to a given level of cyclic AMP was blunted. An explanation for this phenomenon may lie in the fact that cyclic GMP levels in the same hearts were markedly elevated. We have previously shown that acetylcholine and dibutyryl cyclic GMP attenuate the positive inotropic effects of isoproterenol in guinea pig hearts without altering the amount of cyclic AMP formed in response to the catecholamine (Watanabe and Besch, 1975) . Results of these studies have been confirmed and extended subsequently by Wilkerson and colleagues, who demonstrated that the positive inotropic effects of dibutyryl cyclic AMP were attenuated by dibutyryl cyclic GMP (Wilkerson et al., 1976) . It is possible that cyclic GMP attenuated the intracellular effects of cyclic AMP in the hearts receiving A23187.
When the indirect effects of released histamine were abolished, A23187 became a purely negative inotropic agent. Furthermore, the only substantial biochemical change observed in such hearts was an increase in cyclic GMP levels. The increase in cyclic AMP concentrations was markedly attenuated, and the activation of phosphorylase was absent from the guinea pig hearts; no change in these parameters occurred in the rat hearts. The predominant direct biochemical effect of A23187 in intact hearts was thus an increase in tissue cyclic GMP levels. The threshold concentration of the ionophore for this effect was about 0.01 [iM, and, with the maximal stimulating concentration of the ionophore, cyclic GMP levels rose to more than 90 finol/mg wet weight from a basal value of less than 10 fmol/mg wet weight. It is unclear whether the increase in tissue cyclic GMP levels had any causal relationship with the negative inotropic effects of A23187. In support of this hypothesis are the observations that, when cyclic GMP levels were increased in the absence of an elevation of cyclic AMP levels, there was an associated reduction in contractility. Thus, with low concentrations of A23187, when cyclic GMP levels increased but cyclic AMP concentrations did not change ( Figs. 3 and 4) , there was a negative inotropic effect. Similarly, in metiamidetreated guinea pig hearts and in rat hearts in which cyclic GMP levels were selectively increased, there were negative inotropic effects ( Figs. 6 and 8 ). In addition, several other investigators have suggested that cyclic GMP mediates the negative inotropic effects of acetylcholine (George et al., 1973; Nawrath, 1976 ). On the other hand, we have observed previously a poor correlation between elevations in cyclic GMP content and direct negative inotropic effects of acetylcholine in guinea pig ventricles (Watanabe and Besch, 1975) . More recently, Brooker (1977) and Diamond and colleagues (1977) have also shown an apparent dissociation between changes in tissue cyclic GMP concentrations and contractile properties of cardiac tissue. Thus, the role of cyclic GMP in the observed negative inotropic effects of A23187 remains uncertain. It is possible that the reduction in contractility and the elevation in cyclic GMP levels that occurred with A23187 administration were two parallel and unrelated events. The measurements of ATP and CP concentrations excluded depletion of high energy phosphate stores as the cause of the diminished contractility.
The mechanism by which A23187 increased cyclic GMP levels in the hearts is unknown. One possibility is that the ionophore stimulated guanylate cyclase by transporting calcium into the cell. It is well established that calcium can directly increase guanylate cyclase activity and in fact is required for catalytic activity of this enzyme in intact tissues (Wallach and Pastan, 1976; Schultz et al., 1973) . Moreover, it has been shown previously in other tissues that A23187, presumably by increasing intracellular calcium content, increased tissue cyclic GMP levels (Fain and Butcher, 1976; Smith and Ignarro, 1977) . The development of contracture by hearts exposed to high concentrations of A23187 also suggests that the ionophore indeed acted by increasing intracellular calcium concentrations (Fig. 3) . However, other observations do not suggest that A23187 significantly increased the free calcium ion activity in the myocardial cells. In guinea pig hearts treated with metiamide and in rat hearts, A23187 produced only negative inotropic effects, suggesting that calcium concentrations in the vicinity of contractile proteins in these hearts were not elevated ( Figs. 6 and 8) . Similarly, the calciumsensitive cytoplasmic enzyme phosphorylase b kinase (which was indirectly assessed by measurements of phosphorylase activity ratios) apparently was not modified by the ionophore (figs. 6 and 8). It must be concluded, therefore, that if A23187 elevated cyclic GMP levels by transporting calcium into cells, then the divalent cation was compartmentalized, perhaps in the sarcolemma, because other calcium-sensitive components of the cardiac cell did not appear to have been exposed to increased calcium concentrations.
A23187 transports magnesium and hydrogen ions, in addition to calcium, across biological membranes (Reed, 1976; Reed and Lardy, 1972) . It thus seems possible that some of the effects of the ionophore were secondary to changes in the intracellular concentration of one or both of the former ions. Because under physiological conditions the concentration gradient for hydrogen ions is intracellular-to-extracellular, A23187 transports hydrogen from within to the exterior of the cell, thus producing a relative intracellular alkalosis. The op-timal pH for particulate guanylate cyclase is 7.8 (Hardman and Sutherland, 1969) . Therefore, it is possible that the activity of this enzyme was increased because of a decreased intracellular hydrogen ion concentration that may have resulted from the ionophore. This, in turn, may have elevated tissue cyclic GMP levels. One or more of the foregoing postulated mechanisms may be involved in the effects of A23187 on cyclic GMP levels. The ionophore does not directly stimulate particulate or soluble cardiac guanylate cyclase in vitro (G. Revtyak, A. M. Watanabe, L. R. Jones, H. R. Besch, Jr.: unpublished observations). Likewise, the results with atropine excluded release of endogenous acetylcholine as the mechanism by which A23187 increased cardiac cyclic GMP levels (Table 1) . VOL. 44, No. 4, APRIL 1979 hearts RECENT EVIDENCE suggests that more than one type of nerve innervates the larger cerebral blood vessels. Histological studies support this concept. Thus at least two distinct types of nerve ending can be distinguished in the walls of pial vessels by the use of ultrastructural techniques (Iwayama et al., 1970; Edvinsson et al., 1972; Duckies et al., 1977) . One type of nerve ending seems to correspond to the sympathetic nerves that originate in the superior cervical ganglion; the nature of the other type of nerve ending remains unclear. Corresponding to this ultrastructural evidence, functional studies of cerebral vessels in vitro have distinguished two types of response to transmural nerve stimulation. Stimulation of sympathetic nerves pro-
